Risk of Severe Morbidity and Mortality of Coronavirus Disease 2019 (COVID-19) Among Patients Taking Antihypertensive Medications
- Funded by American Heart Association
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Funder
American Heart AssociationPrincipal Investigator
Unspecified Jaejin AnResearch Location
United States of AmericaLead Research Institution
Kaiser Permanente Southern CaliforniaResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Disease pathogenesis
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Unspecified
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
This team will evaluate antihypertensive medication treatment in patients with confirmed COVID-19 infection and high blood pressure and their results could have an immediate impact on clinical guidance for patient care